Wikipedia:Articles for deletion/ImmunityBio (2nd nomination)


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was delete. Liz Read! Talk! 05:48, 5 June 2022 (UTC)

ImmunityBio
AfDs for this article:


 * – ( View AfD View log | edits since nomination)

No issue with the Refund action and I normally wouldn't re-nominate this as soon as it closed (full disclosure, my close), but the requester has done nothing to refute the concerns raised at the AfD and the concerns remain, as indicated by the restoration of tags. No indication of CORP DEPTH nor any indication of notability Star   Mississippi  01:36, 29 May 2022 (UTC)
 * Note: This discussion has been included in the deletion sorting lists for the following topics: Organizations, Companies,  and Science.  Star   Mississippi  01:36, 29 May 2022 (UTC)


 * Courtesy ping to all those involved in prior AfD, restoration: @Slywriter @Jay @CactiStaccingCrane @HighKing @Graham Beards Star   Mississippi  01:38, 29 May 2022 (UTC)


 * Delete think its mostly WP:TOOSOON and currently fails WP:NCORP as a result. There is no lack of googleable information, but their is a lack of reliable, secondary sources discussing the company in-depth especially outside of its early inclusion in 'Warp Speed' for non-primate human testing. And that coverage is focused on the possible vaccine, not the company.Slywriter (talk) 01:51, 29 May 2022 (UTC)
 * Note: This discussion has been included in the list of New York-related deletion discussions. Shellwood (talk) 08:31, 29 May 2022 (UTC)
 * Delete I'll simply repeat what I said at the previous AfD. Since this is a company the appropriate guidelines is WP:NCORP. I have to agree with the nom. We've some references that discusses the product (the vaccine and its technology or its "billionaire" owner) but the criteria dictates we require references that provide in-depth "Independent Content" about the *company*. Topic fails NCORP.  HighKing++ 19:45, 31 May 2022 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.